Leonard Frank X - Mar 2, 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: President, CNS Cancers US
Signature: Steven Robbins, as attorney in fact for Leonard, Frank X.
Stock symbol: NVCR
Transactions as of: Mar 2, 2023
Transactions value $: -$309,578
Form type: 4
Date filed: 3/3/2023, 03:13 PM
Previous filing: Mar 2, 2023
Next filing: Mar 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Sale	-$286K	-3.8K	-6.02%	$75.32	59.3K	Mar 2, 2023	Direct	F1
transaction	NVCR	Ordinary Shares	Sale	-$23.4K	-308	-0.52%	$76.05	59K	Mar 2, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 2, 2023 pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leonard, Mr. Leonard sold 3,799 shares in multiple trades at prices ranging from $74.89 to $75.88. The price reported above reflects the weighted average sale price. Mr. Leonard hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F2	On March 2, 2023 pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leonard, Mr. Leonard sold 308 shares in multiple trades at prices ranging from $75.95 to $76.14. The price reported above reflects the weighted average sale price. Mr. Leonard hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Content

On March 2, 2023 pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leonard, Mr. Leonard sold 3,799 shares in multiple trades at prices ranging from $74.89 to $75.88. The price reported above reflects the weighted average sale price. Mr. Leonard hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

On March 2, 2023 pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leonard, Mr. Leonard sold 308 shares in multiple trades at prices ranging from $75.95 to $76.14. The price reported above reflects the weighted average sale price. Mr. Leonard hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.